Core Insights - Lymphoma is one of the most common malignant tumors in China, with approximately 100,000 new cases and 47,000 deaths annually, characterized by its diverse manifestations among patients, earning it the title of "the most cunning tumor" [1][2] Group 1: Disease Understanding - Lymphoma originates from lymphocytes and is classified as a type of hematological tumor, with varying presentations in different patients, necessitating personalized treatment strategies [1] - The specific mechanisms behind lymphoma's onset are not fully understood, but factors such as genetics, immune abnormalities, exposure to chemical toxins, radiation, viral infections, and aging are considered significant risk factors [1] Group 2: Prevention and Diagnosis - Public awareness is crucial for prevention, with recommendations to avoid harmful substances, maintain a healthy lifestyle, and undergo regular health check-ups [1] - Accurate diagnosis and comprehensive assessment are essential for developing individualized treatment plans, utilizing modern techniques like next-generation sequencing (NGS) for prognosis and treatment decisions [2] Group 3: Treatment Options - Treatment modalities for lymphoma have expanded significantly, including chemotherapy, radiotherapy, targeted therapy, immunotherapy, cell therapy, and hematopoietic stem cell transplantation [2] - Many lymphomas are now considered "curable," with Hodgkin lymphoma having a cure rate exceeding 80%, and low-risk patients with diffuse large B-cell lymphoma also achieving over 80% cure rates [2] Group 4: Special Considerations - For elderly or frail patients, low-toxicity and high-efficacy treatments such as targeted and immunotherapy provide new avenues for care [3] - Not all patients require chemotherapy, especially older individuals, who may benefit from targeted drugs, monoclonal antibodies, bispecific antibodies, or CAR-T cell therapy as preferred options [4] - Treatment should adhere to the principles of "moderation and optimization," considering patient risk stratification, physical condition, and preferences for personalized care [4]